Altamira Therapeutics Ltd. (CYTOF)

CIK 1601936 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Altamira Therapeutics Ltd..

Recent SEC filings

FiledFormAccession number
Feb 27, 202615-12G0001213900-26-021580
Aug 29, 20256-K0001213900-25-082071
Jun 17, 202525-NSE0001354457-25-000544
Jun 17, 202525-NSE0001354457-25-000544
Jun 11, 20256-K0001213900-25-053451
May 15, 2025SCHEDULE 13G/A0001172661-25-002248
May 9, 20256-K0001213900-25-041560
May 6, 2025SCHEDULE 13D/A0001213900-25-039888
Apr 30, 20256-K0001213900-25-037097
Apr 30, 202520-F0001213900-25-037199
Apr 4, 2025S-80001213900-25-029036
Mar 10, 20256-K0001213900-25-022236
Feb 14, 2025SCHEDULE 13G/A0001172661-25-001302
Dec 20, 20246-K0001213900-24-110771
Nov 14, 2024SC 13G0001172661-24-005081
Oct 4, 20246-K0001213900-24-085537
Sep 24, 20246-K0001213900-24-081199
Sep 19, 20246-K0001213900-24-080300
Sep 18, 2024424B40001213900-24-079889
Sep 17, 2024EFFECT9999999995-24-002863
Sep 16, 2024F-1/A0001213900-24-078764
Sep 16, 2024F-1/A0001213900-24-078891
Aug 22, 2024F-10001213900-24-071896
Jul 12, 2024EFFECT9999999995-24-002147
Jul 8, 2024POS AM0001213900-24-059862